The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort
Open accessPublished version of a preprint
Abstract
The novel respiratory disease COVID-19 produces varying symptoms, with fever, cough, and shortness of breath being common. In older adults, we found that pre-existing dementia is a major risk factor (OR = 3.07, 95% CI: 1.71 to 5.50) for COVID-19 hospitalization in the UK Biobank (UKB). In another UK study of 16,749 patients hospitalized for COVID-19, dementia was among the common comorbidities and was associated with higher mortality. Additionally, impaired consciousness, including delirium, is common in severe cases. The ApoE e4 genotype is associated with both dementia and delirium, with the e4e4 (homozygous) genotype associated with high risk of dementia. We therefore aimed to test associations between ApoE e4 alleles and COVID-19 severity, using the UKB data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, individuals with the ApoE3 allele may be more susceptible to severe forms of COVID-19 disease [183].”
From Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 (2022) · cites this paper as [183]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
Mao, L., Wang, M., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., Miao, X., Hu, Y., et al. (2020) · SSRN Electronic Journal · doi:10.1101/2020.02.22.20026500 · Cited by 909
Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2
Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · doi:10.1101/2020.01.26.919985 · Cited by 860
Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort
Atkins, J. L., Masoli, J. A. H., Delgado, J., Pilling, L. C., Kuo, C., Kuchel, G. A., & Melzer, D. R. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa183 · Cited by 497
Self-citationDocherty, A., Harrison, E., Green, C. A., et al. (2020) · medRxiv · doi:10.1101/2020.04.23.20076042 · Cited by 416
Pilling, L. C., Tamosauskaite, J., Jones, G., Wood, A. R., Jones, L., Kuo, C.-L., Kuchel, G. A., Ferrucci, L., & Melzer, D. (2019) · BMJ · doi:10.1136/bmj.k5222 · Cited by 198
Self-citationTudorache, I. F., Trusca, V. G., & Gafencu, A. V. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2017.05.003 · Cited by 186
Armstrong, J., Rudkin, J., Allen, N. E., Crook, D. W., Wilson, D. J., Wyllie, D. H., & O’Connell, A. M. (2020) · Microbial Genomics · doi:10.1099/mgen.0.000397 · Cited by 129
Cited by
Sorted by citations
Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort
Atkins, J. L., Masoli, J. A. H., Delgado, J., Pilling, L. C., Kuo, C., Kuchel, G. A., & Melzer, D. R. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa183 · Cited by 497
Self-citationD’Agnillo, F., Walters, K.-A., Xiao, Y., Sheng, Z.-M., Scherler, K., Park, J., Gygli, S., Rosas, L. A., Sadtler, K., Kalish, H., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj7790 · Cited by 237
Cognitive impact of COVID-19: looking beyond the short term
Miners, J. S., Kehoe, P. G., & Love, S. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00744-w · Cited by 261
ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response
Wang, C., Zhang, M., Garcia, G., Tian, E., Cui, Q., Chen, X., Sun, G., Wang, J., Arumugaswami, V., & Shi, Y. (2021) · Cell stem cell · doi:10.1016/j.stem.2020.12.018 · Cited by 222
The effects of the COVID-19 pandemic on people with dementia
Numbers, K., & Brodaty, H. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00450-z · Cited by 211
The Immune Response and Immunopathology of COVID-19
Mortaz, E., Tabarsi, P., Varahram, M., Folkerts, G., & Adcock, I. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02037 · Cited by 210
Anastassopoulou, C. G., Γκιζαριώτη, Ζ., Patrinos, G. P., & Tsakris, A. (2020) · Human Genomics · doi:10.1186/s40246-020-00290-4 · Cited by 205
Mok, V., Pendlebury, S. T., Wong, A., Alladi, S., Au, L. W. C., Bath, P. M., Biessels, G. J., Chen, C., Cordonnier, C., Dichgans, M., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12143 · Cited by 206
Sun, B., Tang, N., Peluso, M. J., Iyer, N. S., Torres, L., Donatelli, J. L., Munter, S. E., Nixon, C. C., Rutishauser, R. L., Rodríguez-Barraquer, I., et al. (2021) · Cells · doi:10.3390/cells10020386 · Cited by 190
The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease
Brown, E. G., Chahine, L. M., Goldman, S. M., Korell, M., Mann, E., Kinel, D. R., Arnedo, V., Marek, K. L., & Tanner, C. M. (2020) · Journal of Parkinson's Disease · doi:10.3233/jpd-202249 · Cited by 177
The role of high cholesterol in SARS-CoV-2 infectivity
Wang, H., Yuan, Z., Pavel, M. A., Jablonski, S. M., Jablonski, J. A., Hobson, R. J., Valente, S. T., Reddy, C. B., & Hansen, S. B. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104763 · Cited by 178
Tsapanou, A., Papatriantafyllou, J. D., Yiannopoulou, K. G., Sali, D., Kalligerou, F., Ntanasi, E., Zoi, P., Margioti, E. S., Kamtsadeli, V., Hatzopoulou, M., et al. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5457 · Cited by 151
Interactions of SARS-CoV-2 with the Blood–Brain Barrier
Erickson, M. A., Rhea, E. M., Knopp, R. C., & Banks, W. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052681 · Cited by 155
Frontera, J. A., Boutajangout, A., Masurkar, A. V., Betensky, R. A., Ge, Y., Vedvyas, A., Debure, L., Moreira, A., Lewis, A., Huang, J., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12556 · Cited by 157
Integrated gut virome and bacteriome dynamics in COVID-19 patients
Cao, J., Wang, C., Zhang, Y., Lei, G., Xu, K., Zhao, N., Lu, J., Meng, F., Yu, L., Yan, J., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1887722 · Cited by 140
COVID-19 and Alzheimer’s disease: how one crisis worsens the other
Xia, X., Wang, Y., & Zheng, J. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00237-2 · Cited by 138
Population Risk Factors for COVID-19 Mortality in 93 Countries
Hashim, M. J., Alsuwaidi, A. R., & Khan, G. (2020) · Journal of Epidemiology and Global Health · doi:10.2991/jegh.k.200721.001 · Cited by 132
Itzhaki, R. F. (2021) · Vaccines · doi:10.3390/vaccines9060679 · Cited by 126
Infectious agents and Alzheimer's disease
Piekut, T., Hurła, M., Banaszek, N., Szejn, P., Dorszewska, J., Kozubski, W., & Prendecki, M. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102073 · Cited by 123
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
Amruta, N., Chastain, W. H., Paz, M., Solch-Ottaiano, R. J., Murray-Brown, I. C., Befeler, J. B., Gressett, T. E., Longo, M. T., Engler-Chiurazzi, E. B., & Bix, G. J. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.02.002 · Cited by 123
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease
Rahman, M. A., Islam, K., Rahman, S., & Alamin, M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02177-w · Cited by 121
Bello‐Chavolla, O. Y., González-Díaz, A., Antonio‐Villa, N. E., Fermín‐Martínez, C. A., Márquez‐Salinas, A., Vargas‐Vázquez, A., Bahena-López, J. P., García‐Peña, C., Aguilar-Salinas, C. A., & Gutiérrez‐Robledo, L. M. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa163 · Cited by 117
Impact of Allergic Rhinitis and Asthma on COVID-19 Infection, Hospitalization, and Mortality
Ren, J., Pang, W., Luo, Y., Cheng, D., Qiu, K., Rao, Y., Zheng, Y., Dong, Y., Peng, J., Hu, Y., et al. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.10.049 · Cited by 116
COVID-19 and Alzheimer’s Disease
Ciaccio, M., Sasso, B. L., Scazzone, C., Gambino, C. M., Ciaccio, A. M., Bivona, G., Piccoli, T., Giglio, R. V., & Agnello, L. (2021) · Brain Sciences · doi:10.3390/brainsci11030305 · Cited by 116
Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19
Solanich, X., Vargas‐Parra, G., van der Made, C. I., Simons, A., Schuurs-Hoeijmakers, J. H. M., Antolí, A., Valle, J. D., Rocamora-Blanch, G., Setién, F., Esteller, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719115 · Cited by 111
ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank
Kuo, C., Pilling, L. C., Atkins, J. L., Masoli, J. A. H., Delgado, J., Kuchel, G. A., & Melzer, D. R. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa169 · Cited by 108
Self-citationRisk factors and outcomes of COVID‐19 in New York City; a retrospective cohort study
van Gerwen, M. A. G., Alsen, M., Little, C. C., Barlow, J., Genden, E. M., Naymagon, L., & Tremblay, D. A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26337 · Cited by 108
Quan, M., Wang, X., Gong, M., Wang, Q., Li, Y., & Jia, J. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100836 · Cited by 105
Damiano, R. F., Guedes, B. F., de Rocca, C. C., de Pádua Serafim, A., Castro, L. H. M., Munhoz, C. D., Nitrini, R., Filho, G. B., Miguel, E. C., Lucchetti, G., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01286-4 · Cited by 98
Shoemark, D. K., Colenso, C. K., Toelzer, C., Gupta, K., Sessions, R. B., Davidson, A. D., Berger, I., Schaffitzel, C., SPENCER, J. M., & Mulholland, A. J. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202015639 · Cited by 93
Kurki, S., Kantonen, J., Kaivola, K., Hokkanen, L., Mäyränpää, M. I., Puttonen, H. A. J., FinnGen, Martola, J., Pöyhönen, M., Kero, M., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01302-7 · Cited by 96
Maria, E. D., Latini, A., Borgiani, P., & Novelli, G. (2020) · Human Genomics · doi:10.1186/s40246-020-00280-6 · Cited by 93
Mohammadi, S., Moosaie, F., & Aarabi, M. H. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02094-y · Cited by 89
Dementia wellbeing and COVID-19: review and expert consensus on current research and knowledge gaps
Liu, K. Y., Howard, R., Banerjee, S., Comas‐Herrera, A., Goddard, J., Knapp, M., Livingston, G., Manthorpe, J., O'Brien, J. T., Paterson, R. W., et al. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5567 · Cited by 87
Elhabyan, A., Elhabyan, A., Sanad, E., Abukhadra, A., Elhabyan, A., & Dinu, V. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198163 · Cited by 90
Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care
Toniolo, S., the Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel, Scarioni, M., Lorenzo, F. D., Hort, J., Georges, J., Tomić, S., Nobili, F. M., & Frederiksen, K. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210335 · Cited by 86
Neurocognitive Impairment in Long COVID: A Systematic Review
Panagea, E., Messinis, L., Petri, M. C., Liampas, I., Anyfantis, E., Nasios, G., Patrikelis, P., & Kosmidis, M. H. (2024) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acae042 · Cited by 94
Correlations between COVID-19 and burden of dementia: An ecological study and review of literature
Azarpazhooh, M. R., Amiri, A., Morovatdar, N., Steinwender, S., Ardanı, A. R., Yassi, N., Biller, J., Stranges, S., Belasi, M. T., Neya, S. K., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117013 · Cited by 84
Hawkins, M., Sockalingam, S., Bonato, S., Rajaratnam, T., Ravindran, M., Gosse, P. J., & Sheehan, K. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110350 · Cited by 79
Neuropathological findings in two patients with fatal COVID‐19
Jensen, M. P., Quesne, J. P. C. L., Officer‐Jones, L., Teodòsio, A., Thaventhiran, J. E. D., Ficken, C., Goddard, M. J., Smith, C., Menon, D. K., & Allinson, K. S. J. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12662 · Cited by 79
Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation
Komaroff, A. L., Pellett, P. E., & Jacobson, S. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00143-20 · Cited by 77
Manca, R., Marco, M. D., Ince, P. G., & Venneri, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646908 · Cited by 77
Hilser, J. R., Han, Y. Y., Biswas, S., Gukasyan, J., Cai, Z., Zhu, R., Tang, W. H. W., Deb, A., Lusis, A. J., Hartiala, J., et al. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100061 · Cited by 75
Genetic and epigenetic factors associated with increased severity of Covid‐19
Yildirim, Z., Sahin, O. S., Yazar, S., & Çetintaş, V. B. (2021) · Cell Biology International · doi:10.1002/cbin.11572 · Cited by 72
Dementia is a predictor for mortality outcome from coronavirus disease 2019 (COVID-19) infection
Hariyanto, T. I., Putri, C., Situmeang, R. F. V., & Kurniawan, A. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01205-z · Cited by 68
APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients
Zhang, H., Shao, L., Lin, Z., Long, Q.-X., Yuan, H., Cai, L., Jiang, G., Guo, X., Yang, R., Zhang, Z., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01118-4 · Cited by 67
Common human genetic variants of APOE impact murine COVID-19 mortality
Ostendorf, B. N., Patel, M. A., Bilanovic, J., Hoffmann, H.-H., Carrasco, S. E., Rice, C. M., & Tavazoie, S. F. (2022) · Nature · doi:10.1038/s41586-022-05344-2 · Cited by 69
Artificial and Internet of Healthcare Things Based Alzheimer Care During COVID 19
Jesmin, S., Kaiser, M., & Mahmud, M. (2020) · BI · doi:10.1007/978-3-030-59277-6_24 · Cited by 36
Gupta, K., Kaur, G., Pathak, T., & Banerjee, I. (2022) · Gene · doi:10.1016/j.gene.2022.146790 · Cited by 68
Dieter, C., Brondani, L. D. A., Leitão, C., Gerchman, F., Lemos, N. E., & Crispim, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270627 · Cited by 48
Implementing Remote Memory Clinics to Enhance Clinical Care During and After COVID-19
Owens, A. P., Ballard, C. G., Beigi, M., Kalafatis, C., Brooker, H. J., Lavelle, G., Brønnick, K., Sauer, J., Boddington, S., Velayudhan, L., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.579934 · Cited by 58
Zhou, J., Liu, C., Sun, Y., Huang, W., & Ye, K. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.10.019 · Cited by 62
The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms
Chen, F., Chen, Y., Wang, Y., Ke, Q., & Cui, L. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00316-y · Cited by 63
Apolipoprotein E and viral infection: Risks and Mechanisms
Chen, F., Ke, Q., Wei, W., Cui, L., & Wang, Y. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.07.031 · Cited by 60
Kumar, D., Jahan, S., Khan, A., Siddiqui, A. J., Redhu, N. S., Wahajuddin, M., Khan, J., Banawas, S., Alshehri, B., & Alaidarous, M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02318-9 · Cited by 60
Goossens, G. H., Dicker, D., Farpour‐Lambert, N. J., Frühbeck, G., Müllerová, D., Woodward, E., & Holm, J. (2020) · Obesity Facts · doi:10.1159/000510719 · Cited by 58
Khasanova, D. R., Zhitkova, Y. V., & Рушановна, В. Г. (2021) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2021-3-93-98 · Cited by 60
Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action
Abate, G., Memo, M., & Uberti, D. (2020) · Healthcare · doi:10.3390/healthcare8030286 · Cited by 56
Keng, A., Brown, E. E., Rostas, A., Rajji, T. K., Pollock, B. G., Mulsant, B. H., & Kumar, S. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.573367 · Cited by 56
Martín‐Jiménez, P., Muñoz-García, M. I., Seoane, D., Roca-Rodríguez, L., García‐Reyne, A., Lalueza, A., de la Calle, G. M., Folgueira, D., Blanco-Palmero, V. A., Martín, A. H. S., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200937 · Cited by 56
Coping with Dementia in the Middle of the COVID-19 Pandemic
Ryoo, N., Pyun, J., Baek, M. J., Suh, J., Kang, M. J., Wang, M. J., Youn, Y. C., Yang, D. W., Kim, S. Y., Park, Y. H., et al. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e383 · Cited by 58
Wei, G., Diehl‐Schmid, J., Matías‐Guiu, J. A., Pijnenburg, Y. A. L., Landín-Romero, R., Bogaardt, H., Piguet, O., & Kumfor, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-05687-w · Cited by 56
Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?
Rudnicka-Drożak, E., Drożak, P., Mizerski, G., Zaborowski, T., Ślusarska, B. J., Nowicki, G., & Drożak, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032146 · Cited by 57
COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy
Novelli, G., Biancolella, M., Mehrian‐Shai, R., Colona, V. L., Brito, A. F., Grubaugh, N. D., Vasiliou, V., Luzzatto, L., & Reichardt, J. K. V. (2021) · Human Genomics · doi:10.1186/s40246-021-00326-3 · Cited by 51
Prior diagnoses and medications as risk factors for COVID-19 in a Los Angeles Health SystemPreprint
Chang, T. S., Ding, Y., Freund, M. K., Johnson, R., Schwarz, T., Yabu, J. M., Hazlett, C. J., Chiang, J. N., Wulf, A., UCLA Health Data Mart Working Group, et al. (2020) · medRxiv · doi:10.1101/2020.07.03.20145581 · Cited by 49
Dolan, M. E., Hill, D. P., Mukherjee, G., McAndrews-Hill, M., Chesler, E. J., & Blake, J. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-77632-8 · Cited by 50
Covino, M., Russo, A., Salini, S., Matteis, G. D., Simeoni, B., Polla, D. A. D., Sandroni, C., Landi, F., Gasbarrini, A., & Franceschi, F. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.07.005 · Cited by 50
Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture
Yuan, Z., Pavel, M. A., Wang, H., Kwachukwu, J. C., Mediouni, S., Jablonski, J. A., Nettles, K. W., Reddy, C. B., Valente, S. T., & Hansen, S. B. (2022) · Communications Biology · doi:10.1038/s42003-022-03841-8 · Cited by 69
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection
Duff, E. P., Zetterberg, H., Heslegrave, A., Dehghan, A., Elliott, P., Allen, N. E., Runz, H., Laban, R., Veleva, E., Whelan, C. D., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03426-4 · Cited by 61
Dolatshahi, M., Sabahi, M., & Aarabi, M. H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02236-2 · Cited by 51
Huang, P., Zhang, L., Tan, Y., & Chen, S. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00337-1 · Cited by 54
Impact of COVID-19 Pandemic on Patients With Neurodegenerative Diseases
Hu, C., Chen, C., & Dong, X.-P. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.664965 · Cited by 52
Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again?
Xiong, N., Schiller, M. R., Li, J., Chen, X., & Lin, Z. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00858-9 · Cited by 45
del Ser, T., Fernández‐Blázquez, M. A., Valentí, M., Zea‐Sevilla, M. A., Frades, B., Alfayate, E., Saiz-Aúz, L., Calero, O., López, F. J. G., Rábano, A., et al. (2021) · Gerontology · doi:10.1159/000513182 · Cited by 45
Influence of Diabetes Duration and Glycemic Control on Dementia: A Cohort Study
Li, F., Yang, H., Zhou, R., Zheng, J., Chen, G., Wu, X., Zou, M., Wang, J.-Y., Fu, Q. J., & Wu, X. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab221 · Cited by 43
Preexisting Mental Disorders Increase the Risk of COVID-19 Infection and Associated Mortality
Wang, Y., Yang, Y., Ren, L., Shao, Y., Tao, W., & Dai, X. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.684112 · Cited by 48
Genetic susceptibility to severe COVID-19
Cappadona, C., Rimoldi, V., Paraboschi, E. M., & Asselta, R. (2023) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2023.105426 · Cited by 52
The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer’s Disease Pathology
Cui, H., Su, S., Cao, Y. W., Ma, C., & Qiu, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.684874 · Cited by 43
The Impact of the COVID-19 Pandemic on Alzheimer's Disease and Other Dementias
Gan, J., Liu, S., Wu, H., Chen, Z., Fei, M., Xu, J., Dou, Y., Wang, X., & Ji, Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.703481 · Cited by 42
Manzo, C., Mestres, J. S., Isetta, M., & Castagna, A. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110479 · Cited by 43
COVID-19 enters the expanding network of apolipoprotein E4-related pathologies
Gkouskou, K. K., Vasilogiannakopoulou, T., Andreakos, E., Davanos, N., Gazouli, M., Sanoudou, D., & Eliopoulos, A. G. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101938 · Cited by 43
NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration
Sita, G., Graziosi, A., Hrelia, P., & Morroni, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136984 · Cited by 43
The bidirectional link between HDL and COVID-19 infections
Feingold, K. R. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100067 · Cited by 41
The Role of Immunogenetics in COVID-19
Pojero, F., Candore, G., Caruso, C., Bona, D. D., Groneberg, D. A., Ligotti, M. E., Accardi, G., & Aiello, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052636 · Cited by 42
COVID-19 as a Risk Factor for Alzheimer’s Disease
Golzari-Sorkheh, M., Weaver, D. F., & Reed, M. A. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220800 · Cited by 39
Candesartan could ameliorate the COVID-19 cytokine storm
ELKAHLOUN, A. G., & Saavedra, J. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110653 · Cited by 40
Chronic neurological diseases and COVID-19: Associations and considerations
Meshkat, S., Salimi, A., Joshaghanian, A., Sedighi, S., Sedighi, S., & Aghamollaii, V. (2020) · Translational Neuroscience · doi:10.1515/tnsci-2020-0141 · Cited by 37
Human genetic basis of coronavirus disease 2019
Deng, H., Yan, X., & Yuan, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00736-8 · Cited by 36
Bucholc, M., Bradley, D., Bennett, D., Patterson, L., Spiers, R., Gibson, D. S., Woerden, H. V., & Bjourson, A. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-20176-w · Cited by 43
Variable effects of underlying diseases on the prognosis of patients with COVID-19
Choi, Y. J., Park, J.-Y., Lee, H. S., Suh, J., Song, J. Y., Byun, M. K., Cho, J. H., Kim, H. J., & Park, H. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254258 · Cited by 36
Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection
Savelieff, M. G., Feldman, E. L., & Stino, A. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105715 · Cited by 37
The association of APOE genotype with COVID-19 disease severity
Lord, J. S., Rezaiezadeh, J. S., Yekaninejad, M. S., & Izadi, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-17262-4 · Cited by 35
Neurological sequelae of COVID-19: a review
Peterson, C., Sarangi, A., & Bangash, F. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00379-0 · Cited by 36
Watts, J. A., Grunseich, C., Rodriguez, Y., Liu, Y., Li, D., Burdick, J. T., Bruzel, A., Crouch, R. J., Mahley, R. W., Wilson, S. H., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1107 · Cited by 39
Lathe, R., Schultek, N. M., Balin, B. J., Ehrlich, G. D., Alberi, L. A., Perry, G. L., Breitschwerdt, E. B., Corry, D. B., Doty, R. L., Rissman, R. A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13076 · Cited by 39
Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection
Löscher, W., & Howe, C. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.870868 · Cited by 35
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence
Ragnoli, B., Re, B. D., Galantino, A., Kette, S., Salotti, A., & Malerba, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108945 · Cited by 38
Nikoloudis, D., Kountouras, D., & Hiona, A. (2020) · PeerJ · doi:10.7717/peerj.10402 · Cited by 34
Karaderi, T., Bareke, H., Kunter, İ., Şeytanoğlu, A., Çağnan, I., Balcı, D., Barin, B., Hocaoğlu, M., Rahmioğlu, N., Asilmaz, E., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586111 · Cited by 34
Neuropathological analysis of the brains of fifty-two patients with COVID-19
Wierzba‐Bobrowicz, T., Krajewski, P., Tarka, S., Acewicz, A., Felczak, P., Stępień, T., Golan, M. P., & Grzegorczyk, M. (2021) · Folia Neuropathologica · doi:10.5114/fn.2021.108829 · Cited by 34
Metadata
- Authors
- Kuo, C.-L., Pilling, L. C., Atkins, J. L., Masoli, J. A. H., Delgado, J., Kuchel, G. A., & Melzer, D.
- Affiliations
- UConn Health (US)
- University of Exeter (GB)
- Corresponding author
- Melzer, David
- ORCID
- Venue
- The Journals of Gerontology: Series A
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-26
- Volume
- 75
- Issue
- 11
- Pages
- 2231-2232
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- PMC
- PMC7314139
- OpenAlex
- W3031869734
- Cited by
- 388
- References
- 13
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 32 · 2023: 59 · 2022: 88 · 2021: 117 · 2020: 69
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journals of Gerontology Series A (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Aging (R21AG060018)
- UK Medical Research Council (MR/S009892/1)
- National Institute for Health Research (DRF-2014-07-177)
- Department of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- APOE ε4, COVID-19 severity, Alzheimer's disease risk, dementia, delirium, rs429358, rs7412, genetic susceptibility, older adults, UK Biobank, community-based cohort, SARS-CoV-2, European ancestry, comorbidities, mortality risk, hospitalization risk
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Aged, England, Female, Homozygote, Humans, Male, Pneumonia, Viral, Severity of Illness Index, Survival Analysis, Biological Specimen Banks, Coronavirus Infections, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Apolipoprotein E4, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
